Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1045699

registered interest
date	21/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the outcome of his Department's consultation entitled Calorie labelling for food and drink served outside of the home; and what the timetable is for implementing the recommendations from that consultation.
tabling member constituency	South West Bedfordshire
tabling member printed	Andrew Selous
uin	210542
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>We will publish the results of the consultation on mandating calorie labelling in the out-of-home sector and set out the timetable for further action later this year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/01/2019 16:20:26 answering member 4067 label Biography information for Steve Brine
tabling member	1453 label Biography information for Andrew Selous

1043706

registered interest
date	18/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the status is of negotiations between Roche and NHS England on access to ocrelizumab for people with primary progressive MS on the NHS; and if he will take steps to help the two parties reach an agreement to deliver access to that drug.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	210045
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>In November 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care, met with Roche to discuss life sciences, and briefly discussed the negotiations between Roche and NHS England on ocrelizumab. Similarly, the former Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) met with Roche in December 2018. Both Ministers encouraged the on-going negotiations and agreed that these negotiations needed to continue in order to ensure the best conclusion for both parties, and patients that suffer from primary progressive multiple sclerosis. Those discussions are rightly for NHS England and Roche and it would not be appropriate for Ministers to intervene.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for the treatment of primary progressive multiple sclerosis. NHS England is in discussions with Roche, the manufacturer of ocrelizumab, to seek to agree a commercial agreement that might enable NICE to recommend use of the drug.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 210046 question first answered 23/01/2019 16:22:30 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1043707

registered interest
date	18/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) Roche and (b) NHS England on introducing a managed access scheme for ocrelizumab to made available for people living with primary progressive MS.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	210046
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>In November 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care, met with Roche to discuss life sciences, and briefly discussed the negotiations between Roche and NHS England on ocrelizumab. Similarly, the former Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) met with Roche in December 2018. Both Ministers encouraged the on-going negotiations and agreed that these negotiations needed to continue in order to ensure the best conclusion for both parties, and patients that suffer from primary progressive multiple sclerosis. Those discussions are rightly for NHS England and Roche and it would not be appropriate for Ministers to intervene.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for the treatment of primary progressive multiple sclerosis. NHS England is in discussions with Roche, the manufacturer of ocrelizumab, to seek to agree a commercial agreement that might enable NICE to recommend use of the drug.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 210045 question first answered 23/01/2019 16:22:30 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1043718

registered interest
date	18/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what contingencies are in place to protect against drug price increases in the event of the UK leaving the EU without a deal.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	210053
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>The costs of branded medicines are controlled by the statutory and voluntary schemes for branded medicines. Under those schemes, any price increase needs to be agreed by the Department.</p><p> </p><p>For unbranded generic medicines, the Department encourages competition between suppliers to drive prices down. This means that prices fluctuate because of normal market forces and can go up as well as down. The Department is working with the supply chain to ensure that patients continue to get their medicines and the supply chain for medicines is not interrupted if the United Kingdom leaves the European Union without a deal. In such a scenario it is expected that prices remain stable. There are, however, circumstances that are outside of the control of the Department, for example fluctuations in the exchange rate or an increase in the cost of raw materials that may impact on prices of generic medicines.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 23/01/2019 13:49:23 answering member 1585 label Biography information for Stephen Hammond
tabling member	4658 label Biography information for Alex Sobel

1043001

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much was spent in each of the main categories of NHS commissioner spending as recorded by NHS England by (a) NHS England and (b) clinical commissioning groups in aggregate in (i) 2014-15, (ii) 2015-16, (iii) 2016-17 and (iv) 2017-18.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	209790
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The information requested is attached.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/01/2019 17:15:01 answering member 1585 label Biography information for Stephen Hammond attachment 1 file name PQ209790 attached tables.docx title PQ209790 attached tables
tabling member	4244 label Biography information for Jonathan Ashworth

1043002

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much is planned to be spent in each of the main categories of NHS commissioner spending as recorded by NHS England by (a) NHS England and (b) clinical commissioning groups in aggregate in 2018-19.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	209791
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The information requested is attached.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/01/2019 17:17:18 answering member 1585 label Biography information for Stephen Hammond attachment 1 file name PQ209791 table.docx title PQ209791 attached table
tabling member	4244 label Biography information for Jonathan Ashworth

1043003

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks: General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many GP practices in England are (a) a member and (b) not a member of a primary care network.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	209792
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The information is not held in the format requested and can only be obtained at disproportionate cost.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 209793 question first answered 22/01/2019 17:22:00 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

1043004

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks: General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will list all GP practices in England and the primary care network they are a member of.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	209793
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The information is not held in the format requested and can only be obtained at disproportionate cost.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 209792 question first answered 22/01/2019 17:22:00 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

1043042

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Community Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much of the £4.5 billion allocated to community care in five years' time as part of NHS England’s Long Term Plan is planned to be spent on provisions for people diagnosed with Alzheimer’s disease and dementia.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	209801
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>Dementia remains a key priority for the Government. Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five-year plans, will be brought together in a detailed national implementation plan.</p><p> </p><p>We will continue to work closely with key partners and stakeholders, including the Alzheimer’s Society and other voluntary sector partners, as we support the National Health Service to deliver the commitments set out in the Long Term Plan.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 209802 209805 209807 question first answered 22/01/2019 15:24:13 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams

1043043

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to have secured parity of esteem for dementia with cancer, cardiovascular disease, stroke care, mental health and other conditions supported by NHS England’s Long Term Plan.
tabling member constituency	Oldham East and Saddleworth
tabling member printed	Debbie Abrahams
uin	209802
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>Dementia remains a key priority for the Government. Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five-year plans, will be brought together in a detailed national implementation plan.</p><p> </p><p>We will continue to work closely with key partners and stakeholders, including the Alzheimer’s Society and other voluntary sector partners, as we support the National Health Service to deliver the commitments set out in the Long Term Plan.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 209801 209805 209807 question first answered 22/01/2019 15:24:13 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4212 label Biography information for Debbie Abrahams